MPLILW LIMITED
Company number 13003053 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
MPLILW LIMITED - Analysis Report
Company Number: 13003053
Analysis Date: 2025-07-20 14:20 UTC
Financial Health Assessment Report for MPLILW LIMITED
1. Financial Health Score: B-
Explanation:
MPLILW LIMITED shows signs of financial improvement and stability with positive net current assets and net assets increasing year-on-year. However, the absolute values remain modest, reflecting a very small scale operation typical of a micro-entity. The overdue confirmation statement filing also raises a compliance concern, preventing a higher score.
2. Key Vital Signs
| Metric | 2023 Value | Interpretation |
|---|---|---|
| Current Assets | £7,018 | Healthy short-term resources available |
| Current Liabilities | £4,565 | Short-term obligations; decreased from previous year |
| Net Current Assets | £2,453 | Positive working capital indicating liquidity |
| Net Assets (Shareholders Funds) | £2,453 | Growing equity base; positive financial cushion |
| Share Capital | £100 | Minimal initial investment; typical for small entity |
| Employee Count | 0 | No employees, possibly a sole director operation |
| Filing Status | Confirmation Statement Overdue | Compliance risk; potential penalties and reputational impact |
3. Diagnosis: Financial Vital Signs and Symptoms Analysis
Liquidity & Working Capital: The company exhibits a "healthy cash flow" symptom with net current assets improving from £505 in 2022 to £2,453 in 2023. This indicates the company has sufficient liquid resources to cover its short-term liabilities, reducing the risk of cash crunches.
Solvency: Net assets have steadily increased over the past three years, signaling a strengthening "financial immune system," with equity rising from £417 in 2020 to £2,453 in 2023. This is reassuring for creditors and investors.
Scale & Growth: The company remains very small in scale, consistent with micro-entity status, with no employees reported. This could suggest a sole trader or very lean operation, which may limit growth potential but also reduces fixed overhead risk.
Compliance Health: The overdue confirmation statement is a "symptom of administrative distress." While overdue filings do not directly affect financial health, they can lead to penalties, risk of strike-off, and damage to business reputation if unresolved.
Industry Considerations: Operating in the hospital activities sector (SIC 86101), the company may face regulatory and operational risks typical of healthcare providers, though current data does not show any specific risk symptoms.
4. Prognosis: Future Financial Outlook
Assuming continued prudent management, the company’s financial outlook appears stable with potential for moderate growth in net assets and liquidity. However, the overdue statutory filings, if unaddressed, may lead to regulatory actions that could impair operational continuity or stakeholder confidence.
5. Recommendations: Prescriptions for Financial Wellness
Bring Compliance Up to Date: Prioritize filing the overdue confirmation statement immediately to avoid penalties and maintain good standing with Companies House.
Maintain Cash Reserves: Continue to manage working capital carefully to preserve liquidity and avoid cash flow distress.
Explore Growth Opportunities: Consider modest investments or partnerships to increase scale or diversify revenue streams, especially given the healthcare sector's opportunities.
Monitor Financial Trends: Regularly review financial statements to detect any early symptoms of distress such as declining net current assets or increasing liabilities.
Document Corporate Governance: Enhance record-keeping and ensure all statutory deadlines for filings are tracked and met to maintain "administrative health."
Sign in to generate a free AI analysis of this company — no password needed, just an email link.